Indirect Costs Arising From COVID-19-Related Work Absenteeism From October 2020 to July 2022: A Retrospective Study From Central Greece
- PMID: 40291212
- PMCID: PMC12034293
- DOI: 10.7759/cureus.81358
Indirect Costs Arising From COVID-19-Related Work Absenteeism From October 2020 to July 2022: A Retrospective Study From Central Greece
Abstract
Background and objective The coronavirus disease 2019 (COVID-19) pandemic has resulted in significant indirect costs due to the implementation of safety measures and work absenteeism in various sectors of the economy, thereby impacting productivity. This study aimed to examine the indirect costs of the recent pandemic in Thessalia, Central Greece, from October 2020 to July 2022. Methods This retrospective study focused on retail employees aged 20-70 years with absenteeism of 5-45 days. Indirect costs were assessed using administrative wage and leave data. Results During the study period, 1,400 employees were on sick leave: 971 women (69.36%) with a mean age of 44.4 ±9.67 years and 429 men (30.64%) with a mean age of 39.85 ±11.53 years. The study sample included 311 individuals with confirmed COVID-19. Workforce reduction averaged 2.65 workers per month, with estimated costs of €9,948.50 for employers and €90,214.58 for the National Social Security Institution. Conclusions These findings highlight substantial increases in labor costs incurred due to work absenteeism caused by the COVID-19 pandemic. Future research should explore clinical, demographic, and societal factors influencing COVID-19-related productivity losses, which would help inform strategic resource allocation policies.
Keywords: central greece; cost of illness; covid-19; employers; indirect cost; pandemic; productivity loss; sick leave; social security.
Copyright © 2025, Lampropoulos et al.
Conflict of interest statement
Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Ethics Committee of the Faculty of Medicine, University of Thessaly issued approval 288/15.09.2022. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
Similar articles
-
Productivity loss outcomes and costs among patients with cholangiocarcinoma in the United States: an economic evaluation.J Med Econ. 2023 Jan-Dec;26(1):454-462. doi: 10.1080/13696998.2023.2187604. J Med Econ. 2023. PMID: 36883994
-
Workplace smoking related absenteeism and productivity costs in Taiwan.Tob Control. 2005 Jun;14 Suppl 1(Suppl 1):i33-7. doi: 10.1136/tc.2003.005561. Tob Control. 2005. PMID: 15923446 Free PMC article.
-
The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S34-S41. doi: 10.1093/jcag/gwy050. Epub 2018 Nov 2. J Can Assoc Gastroenterol. 2019. PMID: 31294383 Free PMC article.
-
Indirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United States.Int J Chron Obstruct Pulmon Dis. 2014 Mar 19;9:289-300. doi: 10.2147/COPD.S57157. eCollection 2014. Int J Chron Obstruct Pulmon Dis. 2014. PMID: 24672234 Free PMC article. Review.
-
Impact of Influenza and Influenza-Like Illness on Work Productivity Outcomes: A Systematic Literature Review.Pharmacoeconomics. 2023 Mar;41(3):253-273. doi: 10.1007/s40273-022-01224-9. Epub 2022 Dec 14. Pharmacoeconomics. 2023. PMID: 36515814 Free PMC article.
References
-
- Esther I. Hauben, Pancras C.W. Hogendoorn. Bone Cancer (Second Edition) Vol. 4. Cambridge, MA: Academic Press; 2015. Epidemiology of primary bone tumors and economical aspects of bone metastases; pp. 5–10.
-
- Sick leave due to SARS-CoV-2 infection. Vandersmissen G, Verbeeck J, Henckens P, Van Dyck J, Wuytens C, Molenberghs G, Godderis L. Occup Med (Lond) 2024;74:486–492. - PubMed
-
- World Health Organization. Greece. The current COVID-19 situation. [ Feb; 2024 ]. 2024. https://www.who.int/countries/grc https://www.who.int/countries/grc
LinkOut - more resources
Full Text Sources